2021-2025 Global Therapeutic Drug Monitoring (TDM) Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 28 Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for Suppliers
This new 313-page report from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts by country and market segment for the following assays:
Amikacin
Carbamazepine
Cyclosporin
Digoxin
Everolimus
Gentamicin
Levetiracetam
Lithium
Methotrexate
NAPA/Procainamide
Phenobarbital
Phenytoin
Quinidine
Sirolimus
Tacrolimus
Theophylline
Tobramycin
Topirimate
Valproic Acid
Vancomycin
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This unique worldwide market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 313 pages and 83 tables
U.S. Molecular Diagnostics Market Assessment--2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This report presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic,
USD 3850 View ReportU.K. Molecular Diagnostics Market Assessment--2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This report presents analysis of the UK molecular diagnostics market, including:Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological
USD 3450 View Report2024 Global Therapeutic Drug Monitoring (TDM) Market
2024 Global Therapeutic Drug Monitoring (TDM) Market for 28 Assays--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new 313-page report
USD 6500 View Report2024 Global Therapeutic Drug Monitoring TDM Market
2024 Global Therapeutic Drug Monitoring (TDM) Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 28 Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for
USD 7500 View ReportFill The Form For Sample Request